Skip to content
Get started

GFD Tech 100 · Q4 2026 edition

The top health and bio companies in the GFD Tech 100, Q4 2026

These are the top health and bio companies in the GFD Tech 100, Green Flag Digital's quarterly ranking of 3,337 private tech companies. Each company is scored on three public signals: equity funding (50%), website traffic (25%) and branded search demand (25%).

Six health and bio companies made the Top 100 this quarter, all scored the same way as every other company. There was no 2025 health page, so this is the first edition.

The short answer

As of October 31, 2026, the top three health and bio companies in the GFD Tech 100 are OpenEvidence (#26 overall), WHOOP (#28) and Vera Health (#38). 6 health and bio companies made the overall Top 100 this quarter.

Disclosure. Green Flag Digital sells marketing services and may contact companies on this list. That never affects the score.

Which are the top health and bio companies right now?

The top 6 at a glance, by overall Tech 100 score (out of 10). Overall rank is out of 3,337 private tech companies.

Top health and bio companies, GFD Tech 100, Q4 2026. Data as of October 31, 2026.
#CompanyOverallScore
1OpenEvidence#267.6
2WHOOP#287.6
3Vera Health#387.5
4Suki#577.3
5EliseAI#917.0
6Grow Therapy#997.0

What changed this quarter?

  • 6health and bio companies in the overall Top 100
  • 3closed a verified equity round between May 1 and October 31, 2026
  • +2,932places gained by OpenEvidence, the biggest climb since Q3 2026

The full ranking, company by company

Q3 and Q4 ranks are not fully like for like, because the Q4 run checked every Top 100 round against a primary source. Read moves of more than 500 places with care.

Ranked by the overall Tech 100 score. Signal ranks are out of all 3,337 companies; lower is better. Rounds are equity only and checked against the company's own announcement or a named outlet.

  1. 1

    OpenEvidence

    #26 of 3,337 overall · score 7.6/10 · Up 2,932 from #2,958

    • Funding #108
    • Traffic #153
    • Branded search #383

    Latest equity round: $250M, Sep 16, 2026. Source: forbes.com

  2. 2

    WHOOP

    #28 of 3,337 overall · score 7.6/10 · Up 5 from #33

    • Funding #290
    • Traffic #243
    • Branded search #45

    Latest equity round: $575M, Mar 31, 2026. Source: hitconsultant.net

  3. 3

    Vera Health

    #38 of 3,337 overall · score 7.5/10 · New to the ranking

    • Funding #43
    • Traffic #311
    • Branded search #938

    Latest equity round: $28.5M, Oct 27, 2026. Source: prnewswire.com

  4. 4

    Suki

    #57 of 3,337 overall · score 7.3/10 · Up 2,008 from #2,065

    • Funding #91
    • Traffic #1,765
    • Branded search #286

    Latest equity round: $90M, Oct 12, 2026. Source: healthcaredive.com

  5. 5

    EliseAI

    #91 of 3,337 overall · score 7.0/10 · Up 189 from #280

    • Funding #62
    • Traffic #571
    • Branded search #1,255
  6. 6

    Grow Therapy

    #99 of 3,337 overall · score 7.0/10 · Down 19 from #80

    • Funding #595
    • Traffic #161
    • Branded search #192

    Latest equity round: $150M, Mar 3, 2026. Source: prnewswire.com

From Joe's desk

Now we think it's important for readers to use this as a starting point in their own journey of building shortlists for themselves or clients related to tech companies.

Joe Robison founded Green Flag Digital and runs the Tech 100. These are his opinions, not part of the score.

Questions

Which private health company ranks highest in Q4 2026?

OpenEvidence, at #26 overall with a score of 7.6. WHOOP is #28 and Vera Health #38.

How is this list scored?

With the same score as the main GFD Tech 100: funding (50%), website traffic (25%) and branded search (25%), across 3,337 private tech companies. Data is as of October 31, 2026.

When is the next update?

The next edition is Q1 2027 (data as of January 29, 2027). This page keeps the same address and is updated in place.

Methodology

Every company gets the same three measurements, and this page uses the same score as the main ranking. There is no reweighting by industry.

  • Funding (50%). Total equity raised, the size of the last round and how recently it closed. Debt, grants and tender offers do not count.
  • Website traffic (25%). Last month's visits, the six-month average and the growth between them, so a one-month spike on a small site cannot carry a company.
  • Branded search (25%). How many people search for the company by name, and whether that number is rising over twelve months.

We chose funding recency and volume, both combined and scored as a big chunk. Unique to other lists, we are also pulling keyword search volume data. We have done our own research to verify funding beyond Crunchbase.

The pool is private technology companies with equity funding on record. Each company is filed under one industry by what it sells, as shown on the main ranking. Mobility and logistics has three Top 100 companies this quarter (Waymo, Wonder and Scale), too few for a page of its own; they are on the main ranking.

References

Company-level signals come from Crunchbase (equity rounds), Ahrefs (website traffic and branded search) and our own checks of each company's announcements. Only derived ranks and scores are published here. Leader quotes are printed word for word from the linked source. Round sources for the companies on this page:

  1. OpenEvidence round, Sep 16, 2026: forbes.com
  2. WHOOP round, Mar 31, 2026: hitconsultant.net
  3. Vera Health round, Oct 27, 2026: prnewswire.com
  4. Suki round, Oct 12, 2026: healthcaredive.com
  5. Grow Therapy round, Mar 3, 2026: prnewswire.com

History of this list

There was no 2025 Health & bio page; this Q4 2026 page is the first edition.

The Tech 100 itself moved to a quarterly cycle in 2026. The Q3 2026 edition stays online as an archive, and each industry page now keeps one address and changes its edition in the title, so links to it never go stale.

More resources